Johnson & Johnson

JNJ

Johnson & Johnson

Related content

News |

Asian shares gain as investors shrug off downbeat data

BANGKOK (AP) — Shares were higher in Asia on Friday, despite data suggesting economies are slowing. The advance tracked gains on Wall Street, where...

News |

Kellogg to split into 3; snacks, cereals, plant-based food

Kellogg Co., the maker of Frosted Flakes, Rice Krispies and Eggo, will split into three companies focused on cereals, snacks and plant-based foods.

News |

FDA advisers back Novavax COVID shots as 4th US option

American adults who haven’t yet gotten vaccinated against COVID-19 may soon get another choice, as advisers to the Food and Drug Administration on...

News |

Novavax hopes its COVID shot wins over FDA, vaccine holdouts

GAITHERSBURG, Md. (AP) — Americans may soon get a new COVID-19 vaccine option -- shots made with a more tried-and-true technology than today’s...

News |

Tentative $161.5M settlement reached in WVa opioid trial

CHARLESTON, W.Va. (AP) — Attorneys for the state of West Virginia and two remaining pharmaceutical manufacturers have reached a tentative $161.5...

News |

Idaho announces $119 million opioid crisis settlement

BOISE, Idaho (AP) — Idaho officials on Friday announced a $119 million settlement with drugmaker Johnson & Johnson and three major distributors...

News |

South African firm says it may close its COVID vaccine plant

JOHANNESBURG (AP) — The first factory to produce COVID-19 vaccines in Africa says it has not received enough orders and may stop production within...

News |

Protesters vent fury at French company for staying in Russia

WARSAW, Poland (AP) — A man in a Russian military uniform stood at the entrance of a large home improvement store in Poland's capital, saluting...

News |

FDA restricts J&J's COVID-19 vaccine due to blood clot risk

WASHINGTON (AP) — U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to the ongoing risk of rare...

News |

Moderna Q1 profit triples on robust COVID vaccine sales

COVID-19 vaccine sales helped Moderna triple its net income in a better-than-expected first quarter.

News |

Washington reaches $518M settlement with opioid distributors

SEATTLE (AP) — Months into a complex trial over their role in flooding Washington with highly addictive painkillers, the nation's three largest...

News |

J&J suspends COVID-19 vaccine sales forecast

Johnson & Johnson is suspending sales forecasts for its COVID-19 vaccine only a few months after saying the shot could bring in as much as $3.5...

News |

Asian shares mixed after tech-led rally on Wall Street

BANGKOK (AP) — Stocks were mixed in Asia on Wednesday after a rally on Wall Street led by technology stocks.

News |

J&J's Janssen settles with WVa for $99M in opioid lawsuit

CHARLESTON, W.Va. (AP) — West Virginia will receive $99 million in a settlement finalized Monday with Johnson & Johnson's subsidiary Janssen...

News |

Appeals court: J&J must pay $302M in pelvic mesh case

SAN DIEGO (AP) — A California appeals court has upheld a lower court ruling that Johnson & Johnson must pay penalties to the state for deceptively...

News |

EXPLAINER: Where do US opioid trials, settlements stand?

The effort to hold drug companies, pharmacies and distributors accountable for their role in the opioid crisis has led to a whirlwind of legal...

Sign up for VTM Updates

Form submitted successfully!

VTM Exclusive Reports

Crypto Corner

Learn your NFTs from your BTCs